Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.
PT Siloam International Hospitals Tbk's cash receipts from operating activities for the
three
months ended in Mar. 2026 was €166.5 Mil.
2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.
PT Siloam International Hospitals Tbk's cash payments for the
three
months ended in Mar. 2026 was €-133.9 Mil.
3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.
PT Siloam International Hospitals Tbk's cash payments for the
three
months ended in Mar. 2026 was €0.0 Mil.
4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.
PT Siloam International Hospitals Tbk's cash payments for the
three
months ended in Mar. 2026 was €0.0 Mil.
5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.
PT Siloam International Hospitals Tbk's cash payments for the
three
months ended in Mar. 2026 was €-1.7 Mil.
6. Interest Received:
It represents interest received by the company in the direct cash flow method.
PT Siloam International Hospitals Tbk's cash payments for the
three
months ended in Mar. 2026 was €0.3 Mil.
7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.
PT Siloam International Hospitals Tbk's cash payments for the
three
months ended in Mar. 2026 was €-4.8 Mil.
8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).
PT Siloam International Hospitals Tbk's cash flow from others for the
three
months ended in Mar. 2026 was €-0.0 Mil.
PT Siloam International Hospitals Tbk Cash Flow from Operations Related Terms
PT Siloam International Hospitals Tbk Cash Flow from Operations Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk Cash Flow from Operations Chart
PT Siloam International Hospitals Tbk Cash Flow from Operations Calculation
Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.
Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €133.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Operations of €133.0 Mil mean?
PT Siloam International Hospitals Tbk (FRA:2LS) has a Cash Flow from Operations of €133.0 Mil as of Mar. 2026. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for PT Siloam International Hospitals Tbk and its competitors.
Is PT Siloam International Hospitals Tbk's Cash Flow from Operations too high?
PT Siloam International Hospitals Tbk's current Cash Flow from Operations is €133.0 Mil. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's Cash Flow from Operations compare to HCA and THC?
PT Siloam International Hospitals Tbk's Cash Flow from Operations of €133.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Operations for a Healthcare Providers & Services company?
A good Cash Flow from Operations depends on the Healthcare Providers & Services industry context. However, Cash Flow from Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Operations mean?
A high Cash Flow from Operations can signal that a stock is expensive relative to its fundamentals. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for PT Siloam International Hospitals Tbk and its competitors. PT Siloam International Hospitals Tbk's current Cash Flow from Operations is €133.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
PT Siloam International Hospitals Tbk (FRA:2LS) has a current Cash Flow from Operations of €133.0 Mil. The stock's GF Value™ is €0.12, compared to a current price of €0.09 — trading 21.3% below its estimated fair value. The current Cash Flow from Operations is €133.0 Mil. PT Siloam International Hospitals Tbk's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Operations calculated?
Cash Flow from Operations is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current Cash Flow from Operations is €133.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued.
The current stock price of €0.09 is trading 21.3% below its estimated GF Value™ of €0.12.
Key valuation signals for FRA:2LS:
Cash Flow from Operations: €133.0 Mil
GF Value™: €0.12 vs. price of €0.09 (21.3% below fair value)
No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Siloam International Hospitals Tbk Business Description
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
85GF Score
Get the complete analysis for FRA:2LS
Cash Flow from Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2LS has been successfully added to your 
